Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-18

Clinical Trial Update: Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1) [NA]

View source ↗

Summary

A clinical trial is investigating neuromodulation to enhance brain connectivity in schizophrenia and is currently recruiting at UT Health Houston.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Schizophrenia | NA | Status: RECRUITING